The biology of thymic stromal lymphopoietin (TSLP)
- PMID: 23433457
- PMCID: PMC4169878
- DOI: 10.1016/B978-0-12-404717-4.00004-4
The biology of thymic stromal lymphopoietin (TSLP)
Abstract
Originally shown to promote the growth and activation of B cells, thymic stromal lymphopoietin (TSLP) is now known to have wide-ranging impacts on both hematopoietic and nonhematopoietic cell lineages, including dendritic cells, basophils, eosinophils, mast cells, CD4⁺, CD8⁺ and natural killer T cells, B cells and epithelial cells. While TSLP's role in the promotion of TH2 responses has been extensively studied in the context of lung- and skin-specific allergic disorders, it is becoming increasingly clear that TSLP may impact multiple disease states within multiple organ systems, including the blockade of TH1/TH17 responses and the promotion of cancer and autoimmunity. This chapter will highlight recent advances in the understanding of TSLP signal transduction, as well as the role of TSLP in allergy, autoimmunity and cancer. Importantly, these insights into TSLP's multifaceted roles could potentially allow for novel therapeutic manipulations of these disorders.
Copyright © 2013 Elsevier Inc. All rights reserved.
References
Publication types
MeSH terms
Substances
Grants and funding
- R01 AR055695/AR/NIAMS NIH HHS/United States
- P01 HL098067/HL/NHLBI NIH HHS/United States
- R21 HL102708/HL/NHLBI NIH HHS/United States
- HL102708/HL/NHLBI NIH HHS/United States
- AR056113/AR/NIAMS NIH HHS/United States
- AR059058/AR/NIAMS NIH HHS/United States
- 5AR055695/AR/NIAMS NIH HHS/United States
- R01 AR056113/AR/NIAMS NIH HHS/United States
- HL098067/HL/NHLBI NIH HHS/United States
- AI068731/AI/NIAID NIH HHS/United States
- R01 AI068731/AI/NIAID NIH HHS/United States
- T32 AI007411/AI/NIAID NIH HHS/United States
- 5T32AI007411-19/AI/NIAID NIH HHS/United States
- R01 AR059058/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
